Ajanta Pharma Ltd. FDA Record
- Latest inspection VAI · Apr 21, 2026
- No warning letters matched by name
Ajanta Pharma Ltd. has 3 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Ajanta Pharma Ltd." is on file.
- Latest recall
- D-0514-2026 · Class II · Apr 29, 2026
- Latest inspection
- Apr 21, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 9 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Ajanta Pharma Ltd.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 3 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 2 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Ajanta Pharma Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Ajanta Pharma Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0514-2026 | Class II | Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30… | Apr 29, 2026 |
| D-0516-2026 | Class II | Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA… | Apr 29, 2026 |
| D-0515-2026 | Class II | Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA… | Apr 29, 2026 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 21, 2026 | Paithan, India | Drugs | Voluntary Action Indicated (VAI) | 3006785788 |
| Mar 5, 2024 | Paithan, India | Drugs | No Action Indicated (NAI) | 3006785788 |
| Jun 23, 2023 | Bharuch, India | Drugs | No Action Indicated (NAI) | 3012664809 |
| Jun 28, 2019 | Paithan, India | Drugs | Voluntary Action Indicated (VAI) | 3006785788 |
| Jun 22, 2019 | Bharuch, India | Drugs | Voluntary Action Indicated (VAI) | 3012664809 |
| Feb 9, 2018 | Bharuch, India | Drugs | No Action Indicated (NAI) | 3012664809 |
| Feb 7, 2017 | Paithan, India | Drugs | Voluntary Action Indicated (VAI) | 3006785788 |
| Mar 20, 2015 | Paithan, India | Drugs | Voluntary Action Indicated (VAI) | 3006785788 |
| Sep 6, 2012 | Paithan, India | Drugs | Voluntary Action Indicated (VAI) | 3006785788 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006785788 | Paithan, India | 6 | Apr 21, 2026 |
| FEI 3012664809 | Bharuch, India | 3 | Jun 23, 2023 |
Ajanta Pharma Ltd. and the FDA: common questions
Has Ajanta Pharma Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Ajanta Pharma Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Ajanta Pharma Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Ajanta Pharma Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Ajanta Pharma Ltd.?
The most recent FDA inspection on file ended Apr 21, 2026 at Paithan, India and was classified VAI. FDA has 9 inspections of Ajanta Pharma Ltd. on file.
Has Ajanta Pharma Ltd. had an FDA recall?
Yes. Ajanta Pharma Ltd. has 3 FDA recalls on record. The most recent started Apr 29, 2026.
Need more than this page shows? Ask about Ajanta Pharma Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.